Subscribe to MDT Magazine News

Merit Medical Partners With Verite Mobile Tools and Strategies to Create an Innovative Medical Device Conversion App

February 6, 2013 9:00 am | by The Associated Press | Merit Medical Systems, Inc. | Comments

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, and Vérité, a digital communications agency, announced the release of a cutting-edge iPhone App, Merit Convert, available on...


TherOx Begins IDE Study of Next-Generation Supersaturated Oxygen Therapy for AMI

February 6, 2013 8:00 am | by The Associated Press | Comments

IRVINE, Calif.--(BUSINESS WIRE)--Feb 6, 2013--TherOx, Inc., a privately held medical device company focused on the treatment of Acute Myocardial Infarction (AMI), today announced the initiation of its multicenter Investigational Device Exemption (IDE) pilot study of a second generation system that...


Vasomedical, Inc. to Present Live Webcast at on February 7th

February 6, 2013 8:00 am | by PR Newswire | Comments

NEW YORK, Feb. 6, 2013 /PRNewswire/ -- Vasomedical, Inc. ("Vasomedical") (OTC BB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP® systems, the gold standard of ECP...


Innocoll Announces Publication of Clinical Data for XaraColl@ and Regulatory Approval of CollaGUARD@ in India

February 6, 2013 7:01 am | by The Associated Press | Comments

Innocoll, Inc. announced that the following series of three articles presenting Phase 2 clinical data for its bupivacaine-collagen implant, XaraColl@, have recently been published in the Journal of Pain Research (JPR): Clinical evaluation of XaraColl@, a bupivacaine-collagen implant, for ...


SurModics to Webcast Annual Meeting on February 11

February 6, 2013 7:00 am | by The Associated Press | SurModics, Inc. | Comments

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Feb 6, 2013--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Monday, February...


Sensortech Announces New, Ligament Balancing TKA Smart Insert

February 6, 2013 6:31 am | by The Associated Press | Comments

Sensortech Corporation announced advancement of their new, orthopedic knee alignment product, the Force Check Knee Replacement Smart Insert designed for improving total knee arthroplasty (TKA) surgeries. Incorporating FDA-approved Bluetooth 4 low energy technology, and FDA-approved plastics...


Abiomed Announces Revenue of $38.3 Million, Up 19% and Record Impella Patient Usage, Up 26%

February 6, 2013 3:44 am | by GlobeNewswire | Comments

Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2013 revenue of $38.3 million, up 19% compared to revenue of $32.2 million in the same period of fiscal 2012, on record quarterly patient usage, up 26% compared to the same period of fiscal 2012.


ZOLL Receives Shonin Approval from Japan to Market Intravascular Temperature Management Technology

February 6, 2013 12:05 am | by The Associated Press | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--Feb 6, 2013--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to enter the Japanese market with its Intravascular Temperature...


Class II Special Controls Guideline: Temporary Mandibular Condyle Reconstruction Plate

February 6, 2013 12:00 am | by U.S. Food & Drug Administration | Comments

The FDA has developed this draft guideline as the special controls to support the reclassification of the temporary mandibular condyle reconstruction plate (TMCRP) from class III to class II (special controls), which is being issued as a proposed order..


Webinar - What a UDI System can do for Patients and Consumers

February 6, 2013 12:00 am | by U.S. Food & Drug Administration | Comments

Successful UDI implementation offers a number of potential benefits for patients and consumers, including faster detection of safety concerns associated with specific devices, more efficient communication between providers and patients regarding...


MichBio Joins AdvaMed to Unveil State-Based Competitiveness Agenda

February 5, 2013 4:53 pm | by The Associated Press | Comments

WASHINGTON--(BUSINESS WIRE)--Feb 5, 2013--The Advanced Medical Technology Association (AdvaMed), in conjunction with the State Medical Technology Alliance (SMTA) – a network of state-based industry associations that includes MichBio – today released a comprehensive state-based policy agenda aimed...

Kips Bay Medical Announces the First U.S. Implant in the eMESH I Clinical Feasibility Trial

February 5, 2013 4:50 pm | by The Associated Press | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Feb 5, 2013--Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS) announced that on February 5, 2013, the first U.S. patient was implanted with the eSVS ® Mesh at the Northeast Georgia Heart Center in Gainesville, Georgia. This implant was...


Sparton Corporation Reports $0.43 EPS for Fiscal 2013 Second Quarter

February 5, 2013 4:41 pm | by The Associated Press | Comments

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Feb 5, 2013--Sparton Corporation (NYSE: SPA) today announced results for the second quarter of fiscal 2013 ended December 31, 2012. The Company reported second quarter sales of $66.0 million, or an increase of 19.2 %, from $55.4 million for the second quarter of...

House majority leader Eric Cantor decries the medical device tax

February 5, 2013 4:27 pm | by Mass Device | Comments

House majority leader Eric Cantor's (R-Va.) comments on the medical device tax remind that the fight for repeal isn't over. House majority leader Eric Cantor (R-Va.) hasn't forgotten about the the medical device tax, a measure he once called a "draconian" burden on the U.S. medtech industry.


Uroplasty Announces Executive Changes In US Sales Organization

February 5, 2013 4:05 pm | by PR Newswire | Comments

MINNEAPOLIS, Feb. 5, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced changes in its executive leadership for its US sales...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.